Why Canopy Growth (TSX:WEED) Stock Soared 22% Higher This Week

Canopy Growth stock is making a comeback as its valuation improves and a Biden win increases optimism for U.S. cannabis legalization.

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) was the first North American cannabis company to be publicly traded. It has been through many ups and downs as Canada worked hard in the early days of legalization. Management has been shuffled, strategic investors have entered the picture, and a bubble was burst.

This week, we saw renewed optimism and hope coming from this once astronomically valued cannabis stock. Biden is now president-elect, easing the path to federal legalization of cannabis in the United States. And Canopy Growth’s fiscal 2021 second-quarter results and outlook are strong.

In response to all of this, Canopy Growth stock rallied 22% in the last five days, so things are looking up. Read on for more detail.

Canopy Growth posts solid revenue growth in Q2

As the cannabis company that benefits from first mover advantage, Canopy Growth is still the go-to stock for investors. The company has a sizable cash balance of almost $2 billion and is finally forecasting positive adjusted EBITDA.

Adjusted second quarter revenue increased 23%. It’s not the kind of revenue growth that we saw when Canopy Growth first became public, as Canopy Growth stock valuation doesn’t reflect that type of unrealistic growth anyway. Today, the stock’s valuation reflects a more realistic growth path.

As well, it’s better quality revenue growth accompanied by significant cost reductions and market share gains. This, in turn, has led management to forecast that the company will achieve positive adjusted EBITDA at some point in fiscal 2021.

This is all pretty huge. Canopy Growth is making market share gains, opening new stores, and cutting expenses drastically. This is finally a business to consider investing in.

Biden win is positive for federal marijuana reform in the U.S.

Now that Biden has won the U.S. presidential race, that country may further destigmatize and normalize the use of cannabis. Federal legislation may accompany this now that the democrats have gained the presidency.

Biden doesn’t believe that anyone should be in jail for marijuana use. The decriminalization of marijuana is well under way in the U.S. Eleven states already allow for the consumption and/or retail sale of marijuana. According to Gallup polls, 66% of polled Americans favour national legalization of marijuana.

Canopy Growth stock’s valuation reset

In the height of the marijuana bubble, Canopy Growth stock was trading at bubble valuations. Its price to sales multiple was well over 100 times back in 2018. As I pointed out back then, this was not sustainable. And the stock went on the plummet 74.5% from its highs in 2018 to lows of $18.78 in October of 2019.

That’s a far cry from bubble levels. Canopy Growth stock’s price to sales multiple went from a price to sales multiple of over 100 times to today’s multiple of 25 times. I would much rather own the stock today when expectations are more reasonable. The stock is not priced for perfection anymore. The company therefore has a little more wiggle room.

Motley Fool: the bottom line

Canopy Growth stock has rallied in the last week as the market is rewarding the company’s progress. Also, the macro environment is looking better as Biden has won the presidential race. Federal legalization in the U.S. is now looking more plausible.

This cannabis stock has big upside today with much less downside than we have grown accustomed to with this sector. In my view, the risk/reward is very favourable today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »